Polycystic Kidney Disease - ECAB

Author: Dakshinamurty> K V  

Publisher: Elsevier Health Sciences APAC‎

Publication year: 2012

E-ISBN: 9788131231999

P-ISBN(Paperback): 9788131224175

Subject: R692 Nephrology

Keyword: 内科学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Renal cystic diseases include a large number of sporadic and genetically determined congenital, developmental, or acquired conditions. A cyst is a cavity lined by epithelium and filled with fluid. Cysts derive primarily from tubules (from Bowman's capsule to the collecting duct). Cystic kidneys of different etiologies may appear morphologically similar, whereas the same etiologic entity may cause a wide spectrum of renal abnormalities. Simple renal cysts are acquired and are not associated with any disease. In contrast, polycystic kidney diseases can be complicated by renal failure or tumor development. Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal single-gene disorder. Its prevalence at birth is between 1:400 and 1:1,000. It may progress to end stage renal disease by age 60 with 4.4% of patients requiring renal replacement therapy (dialysis or transplant) have ADPKD. The book is a comprehensive guide to diagnosis and management of the condition with special reference and experience around the same in India. The authors have put together the most relevant facts about the disease for an easy comprehension and understanding of the same by practitioners and students across the specialty.

Chapter

Genetics of Autosomal Dominant Polycystic Kidney Disease

ABSTRACT

KEYWORDS:

Introduction

Pkd1

Pkd2

Third Gene

Indian Experience

Two-Hit Suppressor Model Of Cystogenesis

Animal Studies

Diagnosis

Linkage Analysis

Prenatal Testing

Preimplantation Genetic Diagnosis (PGD)

DNA Banking

Conclusions

Pathology, Pathogenesis and Clinical Presentation of Autosomal Dominant Polycystic Kidney Disease

ABSTRACT

KEYWORDS

Introduction

Global Update

Pathology

Pathogenesis

Proliferation of Epithelial Cells

Role of Growth Factor Receptor Proteins

Role of cAMP in Cyst Epithelium Proliferation

Role of Cytokines in Cyst Proliferation

Role of PC-1 and PC-2 Proteins in Cyst Proliferation

Abnormal Secretory Process in Cyst Development and Expansion

Role of Cell Polarity in Abnormal Fluid Secretion and Cyst Expansion

Disturbed Organization of Extracellular Matrix

Cell Matrix Interaction

Cell-Cell Interaction

Other Factors Influencing Cystogenesis

Role of Genes and Their Proteins in ADPKD

Signaling

Role of Apoptosis in Cystogenesis

Role of Primary Cilia in Cystogenesis

Clinical Features

Renal Manifestations

Pain and Renal Size

Hematuria and Cyst Hemorrhage

Urinary Tract Infection and Cyst Infection

Nephrolithiasis

Hypertension

CKD Stage 5

Extrarenal Manifestations

Polycystic Liver Disease

Intracranial Aneurysm (ICA)

Vascular Abnormalities

Valvular Heart Disease

Other Associated Conditions

Acknowledgment

The Diagnosis of Autosomal Dominant Polycystic Kidney Disease

ABSTRACT

KEYWORDS

Genetic Analysis Of Autosomal Dominant Polycystic Kidney Disease

Imaging Studies In The Diagnosis Of Autosomal Dominant Polycystic Kidney Disease

Complications of Autosomal Dominant Polycystic Kidney Disease

ABSTRACT

KEYWORDS

Introduction

Renal Complications

Hematuria

Nephrolithiasis

Flank and abdominal pain

Cancer

Hypertension

Pathogenesis

Treatment

Recommendation

Infection

Diagnosis

Management

Non-response to antibiotic Therapy

Duration of Therapy

Other Interventions

Extrarenal Complications

Cerebral aneurysm

Clinical presentation

Diagnosis

Indications for Intervention

screening Recommendations

Cardiac Disease

Other Vascular abnormalities

Colonic Diverticula

Hernias

Hepatic Cysts

management

Medical Management of Autosomal Dominant Polycystic Kidney Disease

ABSTRACT

KEYWORDS

Molecular Pathogenesis And Targeted Therapeutic Options

Increased Apoptosis in Polycystic Kidney Disease

cAMP-Mediated Pathways

mTOR Activation

Cilia and Cell Cycle Disruption

Triptolide

TREATMENT

Water Intake and Diet

Treatment of Hypertension

Recommendations

HALT-PKD Trial

Vasopressin V2-Receptor Antagonists

Sirolimus

Somatostatin

Conclusions

Surgical Management of Autosomal Dominant Polycystic Kidney Disease Patients

ABSTRACT

KEYWORDS

Introduction

Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients

Renal Cell Carcinoma in Autosomal Dominant Polycystic Kidney Disease Patients

Conclusions

Prognosis of Autosomal Dominant Polycystic Kidney Disease

ABSTRACT

KEYWORDS

Introduction

Prognosis Of Autosomal Dominant Polycystic Kidney Disease

Conclusion

Renal Replacement in Autosomal Dominant Polycystic Kidney Disease Patients

Renal Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients

ABSTRACT

KEYWORDS

Introduction

In addition to routine pretransplant evaluation, do adpkd patients require specific evaluation?

Should potential renal complications require nephrectomy prior to transplantation?

When Transplantation From A Living Relative Is Considered, The Existence Of Adpkd In The Donor Should Be Formally Ruled Ou ...

Is There Any Immunosuppression Protocol That May Have A Favorable Course In Adpkd Patients?

Is there any increased incidence of post-transplant complication in adpkd patients?

As compared to nonadpkd patients, is there an increase in the rate of graft and patient survival in adpkd?

Conclusion

Other Books in This Series

The users who browse this book also browse


No browse record.